| abstract |
Use of an inverse antagonist and/or agonist of CB1 receptors, preferably rimonabant, for preparing drugs that are useful for increasing motor neurone excitability at the level of the cerebral cortex and/or the brainstem and/or at the spinal level, and also a method for increasing motor neurone excitability by means of the administration of an inverse antagonist/agonist of CB1 receptors, and to the use of a pharmaceutical composition that comprises an inverse antagonist and/or agonist of CB1 receptors, preferably rimonabant, for increasing motor neurone excitability at the level of the cerebral cortex and/or the brainstem and/or at the spinal level. |